title: Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
authors.affiliation: Department of Dermatology, Zürich University Hospital, Switzerland.
authors.forename: R
authors.initials: R
authors.lastname: Dummer
authors.forename: A
authors.initials: A
authors.lastname: Hauschild
authors.forename: M
authors.initials: M
authors.lastname: Guggenheim
authors.forename: L
authors.initials: L
authors.lastname: Jost
authors.forename: G
authors.initials: G
authors.lastname: Pentheroudakis
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D054697:Cytostatic Agents / Q000627:therapeutic use; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D016898:Interferon-alpha / Q000627:therapeutic use; D008545:Melanoma / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D009362:Neoplasm Metastasis / Q000628:therapy; D009367:Neoplasm Staging; D011878:Radiotherapy; D016032:Randomized Controlled Trials as Topic; D009418:S100 Proteins / Q000097:blood; D055502:Secondary Prevention; D021701:Sentinel Lymph Node Biopsy; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D054697:Cytostatic Agents; D016898:Interferon-alpha; D009418:S100 Proteins